PLIANT THERAPEUTICS, INC. Debt Securities, Available-for-sale
PLIANT THERAPEUTICS, INC. (PLRX) had Debt Securities, Available-for-sale of $421.40 million as of 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2024-08-07
- 2024-06-30: Debt Securities, Available-for-sale $421.40M.
- 2024-03-31: Debt Securities, Available-for-sale $451.42M.
- 2023-12-31: Debt Securities, Available-for-sale $488.25M.
- 2023-09-30: Debt Securities, Available-for-sale $518.18M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-06-30 | $421.40M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $451.42M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $488.25M 10-Q · filed 2024-08-07 |
| 2023-09-30 | $518.18M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $548.02M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $557.83M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $325.81M 10-K · filed 2024-02-27 |
| 2022-09-30 | $343.06M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $153.10M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $163.05M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $183.76M 10-K · filed 2023-03-09 |
| 2021-09-30 | $203.79M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $233.78M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $243.84M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $263.70M 10-K · filed 2022-03-01 |
| 2020-09-30 | $273.72M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $273.92M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $53.57M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |